According to Faes Farma's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 14.2577. At the end of 2022 the company had a P/E ratio of 12.0.
Year | P/E ratio | Change |
---|---|---|
2022 | 12.0 | -3% |
2021 | 12.4 | -8.56% |
2020 | 13.5 | -36.87% |
2019 | 21.4 | 40.61% |
2018 | 15.2 | -15.21% |
2017 | 18.0 | -21.73% |
2016 | 23.0 | 4.49% |
2015 | 22.0 | 42.04% |
2014 | 15.5 | -37.23% |
2013 | 24.6 | 43.76% |
2012 | 17.1 | 4.1% |
2011 | 16.5 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.